FDA investigators audited the CoValence - Chandler, AZ, United States facility and issued 16 inspectional observations (via FDA 483) on 02 Sep 2016.
Product details
- Category: Human Drugs
- Number of Observations: 16
- Inspection end: 02 Sep 2016
- Location: Chandler, United States
- FEI: 3002408934
